Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New Study Looks to Reverse Alzheimer’s Disease
  • USA - English


News provided by

Apr 23, 2015, 17:30 ET

Share this article

Share toX

Share this article

Share toX

Mount Dora, Florida (PRWEB) April 23, 2015 -- The Thomas Brain Health Center has announced that it intends to conduct a groundbreaking pilot study to see if early Alzheimer’s disease can begin to be reversed in as little as three to six months.

The Center’s researchers—using the science of metabolic and nutritional medicine—will aggressively target and simultaneously treat the numerous underlying conditions that cripple and destroy our aging brain. These include oxidative stress, neuroinflammation, mitochondrial dysfunction, deficiency of neuroactive hormones, cerebral microvascular insufficiency, toxic protein aggregates, synaptic dysfunction, impaired insulin-signaling, and reactive microgliosis.

The research team will obtain before-and-after structural and functional brain imaging (MRI and PET scans), and will perform extensive neurocognitive testing to document the changes. In addition, a television production company will make a documentary showing the progress of the participants throughout the study.

Dr. Daniel Thomas, the Center’s Medical Director, says, “The human brain is extremely complex. Numerous biological systems must work together perfectly in order to maintain optimal brain function and cognitive ability. Alzheimer’s is a multifactorial disease. It is the net result of several dysfunctional conditions and it requires a multipronged approach.”

This is a much better strategy than the one promoted, according to recent news reports, by Silicon Valley billionaires looking for ways to increase human lifespan. They have got it all wrong, says Dr. Thomas citing a BusinessInsider.com article on April 17, 2015 headlined, “Tech billionaires are trying to defeat death.”

http://www.businessinsider.com/tech-billionaires-life-extension-projects-2015-4

These Tech Titans—who have invested hundreds of millions of dollars in the belief that technology can be used to improve longevity—have put their money in the wrong place, says Dr. Thomas.

“What good is it if you extend lifespan but your brain doesn’t come along for the ride? Unless you first find a way to grow new brain cells in the areas that are dead and/or dying, living longer is not worthwhile,” says Dr. Thomas. “Your memories, personality, capacity to love, and your very essence as an individual reside in your brain. Your happiness and quality of life are determined first and foremost by how well your brain works—NOT by how long your body lives. Silicon Valley’s foray into life-extension puts the cart before the horse. You’re not doing a person any favors by extending their life if they aren’t mentally sharp while living it.”

Dr. Thomas issues this challenge to the Tech Titans: “Care to put the horse before the cart and join with me in this important endeavor for mankind?”

While lifespan around the world has risen dramatically with people today living more than 10 years longer than their great grandparents, optimal brain function is not keeping pace, says Dr. Thomas. Even individuals who seem perfectly healthy have brains that are shrinking with age.

Dr. Thomas says, “Brain shrinkage (atrophy) is a silent threat to your health and longevity. Besides costing you memory, intellect, and quality of life, brain atrophy is directly associated with dementia and premature death.”

The incidence of cognitive decline and dementia increases substantially as the brain ages. This is due to the death of brain cells—a degenerative process that is now beginning as early as age 20, studies have revealed. The most pressing medical challenge facing today’s generation and the next, is not heart disease or cancer, Dr. Thomas says, but Alzheimer’s disease.

Conventional treatment for Alzheimer’s has failed, he says. FDA-approved medications such as cholinesterase inhibitors and NMDA-receptor antagonists may reduce symptoms for 6-12 months, but in only about half the people who take them. They do NOTHING to prevent, slow, stop, or reverse the disease process itself.

From time to time, there are reports of drug-based “cures” being developed for Alzheimer’s disease. In the past, all such drugs were ultimately found to be ineffective, and that will likely continue to be the case, asserts Dr. Thomas

ABOUT DR. DANIEL THOMAS, DO, MS: Dr. Thomas has over 25 years of clinical experience and is the Medical Director of the Thomas Brain Health Center, and founder of DementiaQuiz.com. He earned his medical degree from Des Moines University, a Master’s degree in Metabolic and Nutritional Medicine from the University of South Florida College of Medicine, and a Bachelor’s degree in Biochemistry from Andrews University. Dr. Thomas also has a post-doctoral Graduate Certificate in Metabolic Endocrinology from University of South Florida College of Medicine, and is currently completing a Graduate Certificate in Clinical Neuroscience.

Dr. Daniel Thomas, DO, MS, http://www.MaximumBrainHealth.com, +1 (352) 729-0923, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.